Video content above is prompted by the following: Please review the FELIX Study. What are pertinent patient characteristics of this trial - What are some key similarities and differences between FELIX and ZUMA-3? What noteworthy efficacy or safety outcomes were demonstrated? Depth of response, Persistence of CAR-T, and OS Safety What are the clinical implications of this data?